iPSCs Manufacturing Services Market Report Highlights Industry Consolidation and Expansion of Automated Production

InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled “Global iPSCs Manufacturing Services Market  (By Application (Research Products, Drug Development & Discovery, Cellular Therapy, Toxicology Screening, Personalized Medicine, Disease Modelling, Stem Cell Banking, Emerging Applications), End-User(Pharmaceutical & Biotechnology Companies, Academic institutes, Research Laboratories & CROs, Hospitals & Surgical Centers, Cell & Tissue Banks, Other End Users))- Market Outlook and Industry Analysis 2034″

According to the company’s newest research, the Global iPSCs Manufacturing Services Market is worth USD 1.3 billion in 2024 and is predicted to reach 4.6 billion by the year 2034, with a promising CAGR of  14.1 % between 2025 and 2034.

Get Free Access to Demo Report, Excel Pivot, and ToC: https://www.insightaceanalytic.com/request-sample/1223

Induced pluripotent stem cells (iPSCs) have become indispensable in biomedical research and therapeutic development, with applications spanning drug discovery, toxicology assessment, and regenerative medicine. These cells are produced in vitro by reprogramming somatic cells through the targeted expression of key pluripotency-associated transcription factors. While iPSCs do not naturally exist in the human body, they possess the capacity for self-renewal and differentiation into any of the over 220 human cell types, making them critical assets for translational and clinical research initiatives.

iPSC-derived cell types—including hepatocytes, cardiomyocytes, pancreatic islet cells, vascular endothelial cells, and neurons—are extensively utilized in drug development pipelines to evaluate therapeutic efficacy, anticipate toxicity, and model human-specific adverse responses. Providers of iPSC manufacturing services deliver end-to-end solutions, encompassing cell reprogramming and differentiation, cell line characterization, quality control testing, cryopreservation, and cell banking. These services often integrate process optimization, analytical method development, and the production of clinical-grade iPSC therapies.

Automation in iPSC production is projected to register the highest compound annual growth rate (CAGR) over the forecast period, driven by increasing demand for scalable, reproducible, and low-variability manufacturing platforms. National and international iPSC biobanking initiatives targeting conditions such as diabetes, cardiovascular diseases, and neurodegenerative disorders are further facilitating research advancements. Coupled with strategic government funding, rising private sector investment, and a growing number of industry collaborations and acquisitions, these factors are expected to substantially accelerate market expansion in the coming years.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Despite the promising potential of iPSC technologies, market growth may be constrained by the high costs of associated treatments and uncertainties regarding the functional reliability of differentiated tissues. Challenges in optimizing production methods and scaling processes further add complexity to market expansion during the forecast period. Additional barriers for iPSC manufacturing service providers include the limited accessibility of automated production platforms and the technical intricacies involved in genetic modification of iPSCs.

Regionally, North America is anticipated to maintain a dominant position in the iPSC manufacturing services market, driven by rapid advancements in research targeting neuropathies, cardiovascular diseases, and the development of personalized therapeutics. Europe is expected to follow closely, supported by substantial investments aimed at improving iPSC production efficiency and capacity.

Significant market key players are Lonza Group AG, I Peace Inc., Axol Bioscience Ltd., FUJIFILM Cellular Dynamics, Inc., RoslinCT, Takara Bio Inc,  Ncardia, Cynata Therapeutics Limited, Evotec SE, Celogics Inc, Catalent, Inc, CCRM, Applied StemCell Inc. (ASC), Thermo Fisher Scientific, Inc, Other Prominent Players

Key developments in the Market

• In Apr 2022, Ncardia has started a new business called CellisticTM to focus its expertise in induced pluripotent stem cells (iPSC) on the development and production of cell therapies. This strategy builds on Ncardia’s existing drug discovery solutions business and uses the company’s deep expertise in iPSC differentiation and expansion to focus resources and skills on meeting the growing demand for iPSC cell therapy solutions, such as the development of strong manufacturing platforms that are tailored to each cell type.
• In Sept 2021, Fujifilm and Cynata formed a strategic agreement under which Fujifilm will offer commercial and clinical manufacturing services for and supply, Cynata’s CymerusTM therapeutic mesenchymal stem cell (MSC) products.
• In Aug 2021, Catalent bought RheinCell Therapeutics. They planned to speed up access to high-quality iPSC banks by offering integrated solutions for everything from making plasmid DNA to supplying clinical trials.
• In May 2021, an alliance for research and development between BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics was launched to develop cell treatments for ocular illnesses. The firms will pool their resources to find and create commercial iPS cell therapeutics for eye ailments.

Unlock Your GTM Strategy:  https://www.insightaceanalytic.com/customisation/1223

Market Segmentation:

Global iPSCs Manufacturing Services Market, by By Applications, 2022-2030 (Value US$ Mn)

• Research Products
• Drug Development & Discovery
• Cellular Therapy
• Toxicology Screening
• Personalized Medicine
• Disease Modelling
• Stem Cell Banking
• Emerging Applications

Global iPSCs Manufacturing Services Market, by End-User, 2022-2030 (Value US$ Mn)

• Pharmaceutical & Biotechnology Companies
• Academic institutes, Research Laboratories & CROs
• Hospitals & Surgical Centers
• Cell & Tissue Banks
• Other End Users

Global iPSCs Manufacturing Services Market, by region, 2022-2030 (Value US$ Mn)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America IPSCs Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)

• U.S.
• Canada

Europe IPSCs Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)

• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific IPSCs Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)

• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America IPSCs Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa IPSCs Manufacturing Services Market, by Country, 2022-2030 (Value US$ Mn)

• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:

• To receive a comprehensive analysis of the prospects for the global IPSCs Manufacturing Services Market
• To receive an industry overview and future trends of the IPSCs Manufacturing Services Market
• To analyze IPSCs Manufacturing Services Market drivers and challenges
• To get information on the IPSCs Manufacturing Services Market size (Value US$ Mn) forecast to 2030
• Significant investments, mergers & acquisitions in the IPSCs Manufacturing Services Market industry

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Tags: IPSCs Manufacturing Services Market